Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA)

2 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 89.7K shares of 58.9M outstanding shares and own 0.15% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.35M shares), RENAISSANCE TECHNOLOGIES LLC (3.68M shares), VANGUARD GROUP INC (3.46M shares), ACADIAN ASSET MANAGEMENT LLC (2.26M shares), D. E. Shaw & Co., Inc. (2.11M shares), MORGAN STANLEY (2.02M shares), DIMENSIONAL FUND ADVISORS LP (1.97M shares), Pictet Asset Management Holding SA (1.92M shares), Assenagon Asset Management S.A. (1.59M shares), and PRUDENTIAL FINANCIAL INC (1.54M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.